Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
Not yet recruiting
300 enrolled
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Recruiting
2,000 enrolled
Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)
Recruiting
1,000 enrolled
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Recruiting
30 enrolled
BoBCaT
Completed
293 enrolled
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Terminated
2 enrolled
Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer
Recruiting
30 enrolled
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Not yet recruiting
600 enrolled
INFLAMMATE
Enrolling by invitation
4,500 enrolled
PEACE
Not yet recruiting
240 enrolled
POROMS
Completed
30,000 enrolled
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Recruiting
60 enrolled
HRCC1
Terminated
97 enrolled
CAP with NAT
Completed
462 enrolled
Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC
Not yet recruiting
20 enrolled
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
Completed
218 enrolled
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Recruiting
2,000 enrolled
Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Not yet recruiting
50 enrolled
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Not yet recruiting
45 enrolled
Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy
Completed
10,328 enrolled
SELECT
Active not recruiting
707 enrolled
Survival Analysis: TACE vs. Combination Therapy in HCC
Completed
279 enrolled
SUROVA
Unknown
5,000 enrolled
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
Completed
81 enrolled
Muscle Parameters and Pathological Response in Breast Cancer Patients
Completed
69 enrolled
CETC
Recruiting
200 enrolled
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Completed
1,132 enrolled
BiOnHER
Unknown
80 enrolled
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Recruiting
200 enrolled
The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy
Unknown
175 enrolled
I-ONARC
Completed
317 enrolled
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Completed
1,509 enrolled
"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".
Completed
4 enrolled
Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB
Unknown
200 enrolled
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Unknown
120 enrolled
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
Unknown
1,821 enrolled
Registration Study Sarcoma
Recruiting
1,000 enrolled
An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma
Unknown
200 enrolled
LiBReCa
Terminated
25 enrolled
Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy
Unknown
60 enrolled
Chemotherapy for Resectable Colorectal Liver Metastases
Completed
967 enrolled
Acetylamantadine Excretion by Cancer Patients
Unknown
120 enrolled
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
Unknown
100 enrolled
Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients
Unknown
100 enrolled
Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer
Completed
1,067 enrolled
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
Completed
423 enrolled
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Unknown
290 enrolled
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
Completed
418 enrolled
IMET
Unknown
300 enrolled
Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer
Unknown
50 enrolled